Literature DB >> 29886061

Zinc phthalocyanine-soybean phospholipid complex based drug carrier for switchable photoacoustic/fluorescence image, multiphase photothermal/photodynamic treatment and synergetic therapy.

Jinyuan Ma1, Dengyue Chen1, Yang Li2, Yilin Chen1, Qiuhong Liu1, Xinyi Zhou1, Kun Qian3, Zongxi Li1, Hang Ruan1, Zhenqing Hou2, Xuan Zhu4.   

Abstract

For the purpose of precision theranostic of tumor, multifunctional drug delivery systems are always receiving great attentions. Here, we developed a zinc phthalocyanine-soybean phospholipid (ZnPc-SPC) complex based drug delivery system with doxorubicin (Dox) as loading cargo to achieve additional chemotherapy while the carrier itself could serve as multifunctional and switchable theranostic agent. In the early phase, the ZnPc-SPC complex assembled to nanostructure displaying photothermal therapy (PTT) and photoacoustic (PA) properties while in the late phase, the prepared NPs dis-assembled into ZnPc-SPC complex again performing photodynamic therapy (PDT) and low-background fluorescence (FL) image. With the decoration of folate receptors α (FRα) targeted MTX, Dox-loaded, MTX-decorated self-assembled ZnPc-SPC complex NPs (DZSM) was formed. In vitro and in vivo evaluations both indicated that DZSM presented high selectivity for FRα over-expressed tumor cells, excellent switchable PA/FL image, significant multiphase PTT/PDT effect, as well as great synergetic therapy potential, leading to notable inhibition of tumor growth.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fluorescence image; Folate receptor-targeted; Phospholipid complex; Photoacoustic image; Photodynamic treatment; Photothermal treatment; Synergetic therapy; Zinc phthalocyanine

Mesh:

Substances:

Year:  2018        PMID: 29886061     DOI: 10.1016/j.jconrel.2018.06.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Single-molecular phosphorus phthalocyanine-based near-infrared-II nanoagent for photothermal antitumor therapy.

Authors:  Li-Na Zhou; Houhe Pan; Jing-Lan Kan; Qun Guan; Yang Zhou; Yu-Bin Dong
Journal:  RSC Adv       Date:  2020-06-12       Impact factor: 4.036

2.  Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser.

Authors:  Evelyn Y Xue; Roy C H Wong; Clarence T T Wong; Wing-Ping Fong; Dennis K P Ng
Journal:  RSC Adv       Date:  2019-07-02       Impact factor: 4.036

Review 3.  Biomedical Photoacoustic Imaging for Molecular Detection and Disease Diagnosis: "Always-On" and "Turn-On" Probes.

Authors:  Yun Zeng; Taotao Dou; Lei Ma; Jingwen Ma
Journal:  Adv Sci (Weinh)       Date:  2022-06-30       Impact factor: 17.521

Review 4.  Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer.

Authors:  Scott C Hester; Maju Kuriakose; Christopher D Nguyen; Srivalleesha Mallidi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.521

5.  Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer.

Authors:  Jianan Qiao; Fengchun Tian; Yudi Deng; Yunkai Shang; Shijie Chen; Enhao Chang; Jing Yao
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

Review 6.  Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy.

Authors:  Lucimara R Carobeli; Lyvia E de F Meirelles; Gabrielle M Z F Damke; Edilson Damke; Maria V F de Souza; Natália L Mari; Kayane H Mashiba; Cristiane S Shinobu-Mesquita; Raquel P Souza; Vânia R S da Silva; Renato S Gonçalves; Wilker Caetano; Márcia E L Consolaro
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.